4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-23-059261
EVP, Gen. Counsel & Secretary sold 10,519 shares at an average $86.16 ($906,309)
- EVP, Gen. Counsel & Secretary gave up 10,350 shares (to pay taxes)
- EVP, Gen. Counsel & Secretary acquired 16,726 shares (grant or award)
- EVP, Gen. Counsel & Secretary acquired 5,738 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Grant or award | +16,726 | 73,456 | D | ||
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Option exercise | +5,738 | 79,194 | D | ||
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Shares withheld for taxes | −8,713 | $88.60 | $771,972 | 70,481 | D |
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-18 | Shares withheld for taxes | −1,637 | $87.49 | $143,221 | 68,844 | D |
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-18 | Sale | −8,856 | $86.19 | $763,270 | 59,988 | D |
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-19 | Sale | −1,663 | $86.01 | $143,038 | 58,325 | D |
| Derivatives | |||||||
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Grant or award · Performance-Based Restricted Stock Unit | +8,363 | 8,363 | D | ||
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Grant or award · Employee Stock Option (Right to Buy) | +29,316 | 29,316 | D | ||
| SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | 2023-12-15 | Option exercise · Performance-Based Restricted Stock Unit | −5,738 | 0 | D | ||
| Open-market sales · 10,519 sh · avg $86.16 · $906,309 | |||||||
Loading xslF345X05/doc4.xml…